Company profile: PharmAkea
1.1 - Company Overview
Company description
- Provider of biopharmaceutical R&D, developing high-quality small molecule drug candidates against protein targets involved in fibroproliferative diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmAkea
TargeGen
HQ: United States
Website
- Description: Provider of vascular biology-focused small molecule kinase inhibitors targeting vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation, offering treatments for human diseases such as heart attack, cancer, and eye diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TargeGen company profile →
Chiva Pharmaceuticals
HQ: United States
Website
- Description: Provider of global pharmaceutical solutions focused on bringing the best standard of care to the Chinese market and making drugs developed in China available worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chiva Pharmaceuticals company profile →
Senda Biosciences
HQ: United States
Website
- Description: Provider of a therapeutics platform leveraging insights into molecular connections between humans, offering Endless RNA (eRNA) to program proteins inside the body with long-lasting expression, Natural NanoParticle (NNP) technology with nanoparticles derived from nature for targeted delivery of biomolecules into human cells, and AI-driven integrative design of RNA medicines for oncology and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Senda Biosciences company profile →
Reata Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for cancer, inflammation, neurodegenerative, renal, cardiovascular, and autoimmune diseases, including antioxidant and inflammation-modulating drugs and agents that correct protein misfolding. Offers Skyclarys (omaveloxolone), an FDA-approved treatment for Friedreich's Ataxia in patients 16+.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reata Pharmaceuticals company profile →
Redwood Bioscience
HQ: United States
Website
- Description: Provider of precision protein-chemical engineering to develop optimized, novel biotherapeutics using site-specific modification technology to create homogenous biologic-synthetic conjugates; offering microscale perfusion-based cultivation for Pichia pastoris, E. coli recombinant proteins, CagA diagnostic proteins, and KRAS G12D recombinant protein vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Redwood Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmAkea
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmAkea
2.2 - Growth funds investing in similar companies to PharmAkea
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmAkea
4.2 - Public trading comparable groups for PharmAkea
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →